EW vs MRVL · P/E 47, rev $3.39B vs P/E 100, rev $5.16B
Edwards Lifesciences Corp (EW) versus Marvell Technology Group Ltd (MRVL) — a side-by-side from cached financials, not a winner call.
Edwards Lifesciences Corp (EW) is a medical devices company listed on NYSE.
Marvell Technology Group Ltd (MRVL) is a semiconductors company listed on NASDAQ.
Latest reported EW revenue for 2026-06-30 was $3.39B. Net income was $622.6M. EW currently screens at market cap $49.91B and trailing P/E 46.9.
Latest reported MRVL revenue for 2026-08-01 was $5.16B. Net income was $342.5M. MRVL currently screens at market cap $253.51B and trailing P/E 99.8.
EW currently screens at market cap $49.91B and trailing P/E 46.9. MRVL currently screens at market cap $253.51B and trailing P/E 99.8.
Not investment advice. Open the EW and MRVL stock pages for the full models.
Not investment advice.